Redmile Group, LLC Repligen Corp Transaction History
Redmile Group, LLC
- $1.28 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.03 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$739 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$245 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$224 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.04B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....